| Customization: | Available |
|---|---|
| Dosage Form: | Injection |
| Dossier: | Ready |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Generic Name | Pentoxifylline Injection 5ml/0.1g |
| Strength | 5ml/0.1g |
| Packing | 5amps/box |
| Origin | China |
This product is a clear liquid.
Pentoxifylline Injection is a drug suitable for cerebral blood circulation disorders, peripheral blood circulation disorders, and inner ear circulation disorders. 1, cerebral blood circulation disorders such as transient ischemic attack, stroke sequelae, cerebral ischemia caused brain dysfunction; 2, peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or resting pain; 3, inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; Eye blood circulation disorders such as diabetic retinal artery embolism.
Usage and dosage:
Intravenous drip. The patient should be in a supine position. The initial dose of pentoxifylline is 0.1g, input within 23 hours, the maximum drop rate should not exceed 0.1g per hour, according to the patient's tolerance can be increased by 0.05g each time, but each dose should not exceed 0.2g, 12 times a day, the maximum daily dose should not exceed 0.4g.
Matters needing attention:
Pentoxifylline and its metabolites improve hemorrheology by reducing blood viscosity, the exact mechanism of action has not been determined. Pentoxifylline can reduce blood viscosity in a dose-dependent manner, improve the deformability of red blood cells, improve the hemorheological properties of white blood cells, and resist the adhesion and activation of neutrophils. In patients with chronic peripheral artery disease, this product can increase blood flow, improve microcirculation and increase oxygen supply to the tissues.
){kind=link}